Literature DB >> 18823309

Association of polymorphisms in CASP10 and CASP8 with FEV(1)/FVC and bronchial hyperresponsiveness in ethnically diverse asthmatics.

Alicia K Smith1, Leslie A Lange, Elizabeth J Ampleford, Deborah A Meyers, Eugene R Bleecker, Timothy D Howard.   

Abstract

BACKGROUND: Several chromosomal regions have been identified using family-based linkage analysis to contain genes contributing to the development of asthma and allergic disorders. One of these regions, chromosome 2q32-q33, contains a gene cluster containing CFLAR, CASP10 and CASP8. These genes regulate the extrinsic apoptosis pathway utilized by several types of immune and structural cells that have been implicated in the pathogenesis of asthma.
OBJECTIVE: To assess the role of genetic variation in CFLAR, CASP10 and CASP8 in asthma and related phenotypes in individuals of diverse ethnic backgrounds.
METHODS: We tested 26 single nucleotide polymorphisms (SNPs) in the CFLAR, CASP10 and CASP8 gene cluster for association with asthma and related phenotypes in African-American, non-Hispanic whites, and Hispanic case-control populations (cases, N=517, controls, N=644).
RESULTS: Five CASP10 SNPS were associated with forced expiratory volume in 1 s (FEV(1))/forced expiration volume capacity (FVC) in the African-American subjects with asthma (P=0.0009-0.047). Nine SNPs, seven in CASP10 and two in CASP8, were also associated with the degree of bronchial hyperresponsiveness (BHR) (as determined by PC(20)) in race-specific analysis, predominately in the Non-Hispanic white cases. Two SNPs, rs6750157 in CASP10 and rs1045485 in CASP8 were modestly associated with asthma in the African-American (P=0.025) and Hispanic (P=0.033) populations, respectively.
CONCLUSION: These data suggest a role for CASP10 as a potential modifier of the asthma phenotype, specifically with measures of airway obstruction and BHR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823309      PMCID: PMC3979622          DOI: 10.1111/j.1365-2222.2008.03095.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  18 in total

1.  A second-generation genomewide screen for asthma-susceptibility alleles in a founder population.

Authors:  C Ober; A Tsalenko; R Parry; N J Cox
Journal:  Am J Hum Genet       Date:  2000-10-05       Impact factor: 11.025

2.  Score tests for association between traits and haplotypes when linkage phase is ambiguous.

Authors:  Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland
Journal:  Am J Hum Genet       Date:  2001-12-27       Impact factor: 11.025

Review 3.  The pathophysiology of asthma.

Authors:  Lee Maddox; David A Schwartz
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

4.  Genome-wide search for atopy susceptibility genes in Dutch families with asthma.

Authors:  Gerard H Koppelman; O Colin Stine; Jianfeng Xu; Timothy D Howard; Siqun L Zheng; Henk F Kauffman; Eugene R Bleecker; Deborah A Meyers; Dirkje S Postma
Journal:  J Allergy Clin Immunol       Date:  2002-03       Impact factor: 10.793

5.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

Review 6.  New insights into the role of cytokines in asthma.

Authors:  J C Renauld
Journal:  J Clin Pathol       Date:  2001-08       Impact factor: 3.411

7.  Ethnic differences in asthma and associated phenotypes: collaborative study on the genetics of asthma.

Authors:  L A Lester; S S Rich; M N Blumenthal; A Togias; S Murphy; F Malveaux; M E Miller; G M Dunston; J Solway; R L Wolf; J M Samet; D G Marsh; D A Meyers; C Ober; E R Bleecker
Journal:  J Allergy Clin Immunol       Date:  2001-09       Impact factor: 10.793

8.  Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas.

Authors:  Min Sun Shin; Hong Sug Kim; Chang Suk Kang; Won Sang Park; Su Young Kim; Shi Nae Lee; Jong Heun Lee; Jik Young Park; Ja June Jang; Chul Woo Kim; Sang Ho Kim; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

9.  Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.

Authors:  J Wang; L Zheng; A Lobito; F K Chan; J Dale; M Sneller; X Yao; J M Puck; S E Straus; M J Lenardo
Journal:  Cell       Date:  1999-07-09       Impact factor: 41.582

10.  Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease.

Authors:  Edwin K Silverman; Lyle J Palmer; Jonathan D Mosley; Matthew Barth; Jody M Senter; Alison Brown; Jeffrey M Drazen; David J Kwiatkowski; Harold A Chapman; Edward J Campbell; Michael A Province; D C Rao; John J Reilly; Leo C Ginns; Frank E Speizer; Scott T Weiss
Journal:  Am J Hum Genet       Date:  2002-03-25       Impact factor: 11.025

View more
  1 in total

Review 1.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.